| scholarly article | Q13442814 |
| MDMA | Q69488 |
| P356 | DOI | 10.1111/J.1365-2990.2006.00790.X |
| P698 | PubMed publication ID | 17359360 |
| P50 | author | Miklós Palkovits | Q1228428 |
| György Bagdy | Q41173404 | ||
| Gabor G. Kovacs | Q41878022 | ||
| P2093 | author name string | Benedek A | |
| Adori C | |||
| Andó RD | |||
| Kirilly E | |||
| P2860 | cites work | Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB | Q24678394 |
| Ecstasy: are animal data consistent between species and can they translate to humans? | Q31033315 | ||
| (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals | Q33950568 | ||
| Axonal damage: a key predictor of outcome in human CNS diseases | Q34174912 | ||
| The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 | ||
| Anatomy of the serotonergic system | Q34270063 | ||
| Non-linear pharmacokinetics of MDMA ('ecstasy') in humans | Q34507084 | ||
| Brain tryptophan hydroxylase: purification of, production of antibodies to, and cellular and ultrastructural localization in serotonergic neurons of rat midbrain | Q35089051 | ||
| Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine | Q43544200 | ||
| Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat. | Q44777848 | ||
| Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. | Q44843771 | ||
| Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine | Q44948786 | ||
| Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus | Q44974818 | ||
| 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein | Q44987921 | ||
| (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane | Q46529137 | ||
| Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats | Q46629531 | ||
| Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine | Q48180215 | ||
| Immunohistochemistry of tryptophan hydroxylase in the rat brain | Q48196544 | ||
| Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo | Q48273482 | ||
| The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). | Q48374881 | ||
| Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. | Q48481465 | ||
| Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns | Q48536718 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 193-203 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord | |
| P478 | volume | 33 |
| Q43543985 | 3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity |
| Q41669953 | Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake. |
| Q46763655 | Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days |
| Q47927565 | Exploring the role of neuropeptide S in the regulation of arousal: a functional anatomical study |
| Q35078880 | Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats |
| Q58803214 | Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats |
| Q37629259 | Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications |
| Q48878720 | Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain. |
| Q55043421 | Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation. |
| Q34976260 | Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. |
| Q59619127 | Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat |
| Q37925507 | The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis |
| Q59619133 | Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat |
| Q28550342 | Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective |
Search more.